Taubert Jennifer L 4
4 · JOHNSON & JOHNSON · Filed Sep 5, 2025
Insider Transaction Report
Form 4
Taubert Jennifer L
EVP, WWC. Innovative Medicine
Transactions
- Exercise/Conversion
Common Stock
2025-09-04$101.87/sh+56,471$5,752,701→ 234,484.001 total - Exercise/Conversion
Employee Stock Options (Right to Buy)
2025-09-04$101.87/sh−56,471$5,752,701→ 0 totalExercise: $101.87From: 2019-02-09Exp: 2026-02-08→ Common Stock (56,471 underlying) - Sale
Common Stock
2025-09-04$177.81/sh−56,471$10,040,883→ 178,013.001 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $177.715 to $177.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Vested and exercisable one day after the third anniversary of the date of the grant.